menu
    • menu
    [{"orgOrder":0,"company":"Eurofins CDMO","sponsor":"Beacon Discovery","pharmaFlowCategory":"D","therapeuticArea":"Technology","country":"U.S.A","productType":"Small molecule","year":"2021","type":"Acquisition","leadProduct":"Undisclosed","moa":"","graph1":"Technology","graph2":"Discovery","graph3":"Eurofins CDMO","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Technology","amount2New":0,"dosageForm":"","sponsorNew":"Eurofins CDMO \/ Eurofins CDMO","highestDevelopmentStatusID":"2","companyTruncated":"Eurofins CDMO \/ Eurofins CDMO"},{"orgOrder":0,"company":"Eurofins CDMO","sponsor":"Polyrizon","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"","productType":"Undisclosed","year":"2024","type":"Agreement","leadProduct":"PL-14","moa":"","graph1":"Immunology","graph2":"Preclinical","graph3":"Eurofins CDMO","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"","sponsorNew":"Eurofins CDMO \/ Eurofins CDMO","highestDevelopmentStatusID":"4","companyTruncated":"Eurofins CDMO \/ Eurofins CDMO"}]

    Find Clinical Drug Pipeline Developments & Deals by Eurofins CDMO

    Menu

    Eurofins CDMO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    Eurofins CDMO

    France arrow
    ELCC
    Not Confirmed

    Eurofins CDMO

    France arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : PL-14

    Therapeutic Area : Immunology

    Study Phase : Preclinical

    Recipient : Polyrizon

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Polyrizon Enters GMP Manufacturing Agreement for PL-14 Allergy Blocker Trial

    Details : The collaboration will supply Clinical Trial Material for Polyrizon’s PL-14 allergy blocker, in preparation for a clinical trial.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    December 02, 2024

    Lead Product(s) : PL-14

    Therapeutic Area : Immunology

    Highest Development Status : Preclinical

    Recipient : Polyrizon

    Deal Size : Undisclosed

    Deal Type : Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    02

    Eurofins CDMO

    France arrow
    ELCC
    Not Confirmed

    Eurofins CDMO

    France arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Technology

    Study Phase : Discovery

    Recipient : Beacon Discovery

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Dis...

    Details : Eurofins acquired Beacon Discovery for its innovative approach, years of experience in drug discovery and development as well as their profound expertise in GPCR research, complemented by their unique compound library.

    Product Name : Undisclosed

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    February 18, 2021

    Lead Product(s) : Undisclosed

    Therapeutic Area : Technology

    Highest Development Status : Discovery

    Recipient : Beacon Discovery

    Deal Size : Undisclosed

    Deal Type : Acquisition

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth